Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4751802
Max Phase: Preclinical
Molecular Formula: C33H32O11
Molecular Weight: 604.61
Molecule Type: Unknown
Associated Items:
ID: ALA4751802
Max Phase: Preclinical
Molecular Formula: C33H32O11
Molecular Weight: 604.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)c1cc(OC)cc(O)c1C(=O)C1CC2(CCc3cc(OC)cc(C(=O)OC)c3C2=O)C(=O)C2=C(C)OC(C)=CC21
Standard InChI: InChI=1S/C33H32O11/c1-15-9-20-23(28(35)27-22(32(39)43-6)12-19(41-4)13-24(27)34)14-33(29(36)25(20)16(2)44-15)8-7-17-10-18(40-3)11-21(31(38)42-5)26(17)30(33)37/h9-13,20,23,34H,7-8,14H2,1-6H3
Standard InChI Key: ZIIMZWGTLXIGJH-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 604.61 | Molecular Weight (Monoisotopic): 604.1945 | AlogP: 4.39 | #Rotatable Bonds: 6 |
Polar Surface Area: 151.73 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 11 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.83 | CX Basic pKa: | CX LogP: 4.54 | CX LogD: 4.53 |
Aromatic Rings: 2 | Heavy Atoms: 44 | QED Weighted: 0.28 | Np Likeness Score: 0.80 |
1. M Hussain FB,Al-Khdhairawi AAQ,Kok Sing H,Muhammad Low AL,Anouar EH,Thomas NF,Alias SA,Manshoor N,Weber JF. (2020) Structure Elucidation of the spiro-Polyketide Svalbardine B from the Arctic Fungal Endophyte Poaceicola sp. E1PB with Support from Extensive ESI-MS Interpretation., 83 (12): [PMID:33233893] [10.1021/acs.jnatprod.9b01105] |
Source(1):